SCHEMBL10705476

SCHEMBL10705476

CCCCCC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR3C1 P04150 5/20 0.69
▸ CYP3A4 P08684 5/20 0.69
▸ LMNA P02545 5/20 0.69
▸ PGR P06401 4/20 0.69
▸ MAPT P10636 3/20 0.69
▸ HIF1A Q16665 3/20 0.69
▸ SMN1; SMN2 Q16637 3/20 0.69
▸ KMT2A Q03164 2/20 0.69
▸ NPSR1 Q6W5P4 2/20 0.69
▸ HPGD P15428 1/20 0.69
▸ MEN1 O00255 1/20 0.69
▸ MLNR O43193 1/20 0.69
▸ NR1I2 O75469 1/20 0.69
▸ ADORA3 P0DMS8 1/20 0.69
▸ HTT P42858 1/20 0.69
▸ SLC6A3 Q01959 1/20 0.69
▸ PDE4D Q08499 1/20 0.69
▸ PDE3A Q14432 1/20 0.69
▸ NR3C2 P08235 4/20 0.48
▸ AR P10275 4/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10704393 0.98 NR3C1 (0.66) NR3C1CYP3A4LMNAPGRMAPT
SCHEMBL10707423 0.94 NR3C1 (0.59) NR3C1CYP3A4LMNAPGRMAPT
SCHEMBL10703308 0.90 AR (0.54) NR3C1CYP3A4LMNAPGRMAPT
SCHEMBL11799696 0.86 CYP3A4 (0.60) NR3C1CYP3A4LMNAPGRMAPT
SCHEMBL10705465 0.86 CYP3A4 (0.60) NR3C1CYP3A4LMNAPGRMAPT
SCHEMBL10706361 0.85 CYP3A4 (0.56) NR3C1CYP3A4LMNAPGRMAPT
SCHEMBL3940208 0.85 NR3C1 (0.48) NR3C1CYP3A4LMNAPGRMAPT
SCHEMBL11800114 0.85 CYP3A4 (0.55) NR3C1CYP3A4LMNAPGRMAPT
SCHEMBL11800122 0.85 CYP3A4 (0.55) NR3C1CYP3A4LMNAPGRMAPT
SCHEMBL11799756 0.85 CYP3A4 (0.55) NR3C1CYP3A4LMNAPGRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0153270-B1 1-ALPHA, 2-ALPHA-METHYLENE-6-METHYLENE AND 6-ALPHA-METHYL PREGNENES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SCHERING AKTIENGESELLSCHAFT (DE) 1988-07-27 — — EP disclosed
US-4670427-A ANTIANDROGENS SCHERING AKTIENGESELLSCHAFT (DE) 1987-06-02 — — US disclosed
EP-0153270-A2 1-Alpha, 2-alpha-methylene-6-methylene and 6-alpha-methyl pregnenes, process for their preparation and pharmaceutical compositions containing them SCHERING AKTIENGESELLSCHAFT (DE) 1985-08-28 — — EP disclosed
Send feedback